Riskpilot← Back to searchSign inGet full accessLund Science AB
ABActiveOrg 5592885809Klostergatan 2Manufacture of instruments and appliances for measuring, testing and navigation · NACE 2651Est. 20201-4 employees
Revenue 2024
SEK 1,5M
-40% vs 2023
EBITDA margin
-33.9%
-1557% vs 2023
Equity ratio
19.8%
Financial strength
Net profit 2024
SEK -11K
-257% vs 2023
| Revenue | SEK 1,5M | -40% |
| EBITDA | SEK -497K | -1557% |
| Net profit | SEK -11K | -257% |
| Total assets | SEK 2,5M | -19% |
| Equity | SEK 498K | -2% |
| Employees | — | — |
Legal name
Lund Science AB
Org number
5592885809
Legal form
Aktiebolag
NACE code
2651 · Manufacture of instruments and appliances for measuring, testing and navigation
Founded
9 december 2020
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska utveckla, tillverka och marknadsföra instrument och system för mät- och reglertekniska ändamål främst inom fastighetsbranschen.
Address
Klostergatan 2
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 2 524 | 3 838 | 2 457 | 1 466 |
| Staff expenses | — | — | — | — |
| EBITDA | 319 | 451 | −30 | −497 |
| Depreciation & amort. | −21 | −66 | −73 | −77 |
| EBIT | 298 | 385 | −103 | −574 |
| Net financials | −6 | −12 | −22 | −22 |
| Profit before tax | 216 | 275 | 14 | 0 |
| Tax | −50 | −60 | −7 | −11 |
| Net profit | 166 | 215 | 7 | −11 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 2 419 | 2 704 | 3 099 | 2 513 |
| Equity | 191 | 406 | 508 | 498 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 2 151 | 2 124 | 1 995 | 2 016 |
| Total debt | 2 151 | 2 124 | 1 995 | 2 016 |
EBITDA margin
-33.9%
This company
15.8%
Market median
-315% vs market
20212024
Equity ratio
19.8%
This company
38.2%
Market median
-48% vs market
20212024
Return on equity
-2.2%
This company
18.4%
Market median
-112% vs market
20212024
Net profit margin
-0.8%
This company
8.1%
Market median
-110% vs market
20212024
Asset turnover
0.58×
This company
1.12×
Market median
-48% vs market
20212024
Debt / equity
4.05×
This company
0.62×
Market median
-553% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (4) | ||
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Lund Science AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Erik Magnus Bolmsjö | Deputy Board Member | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Sven Magnus Bolmsjö | Board of Directors | 0 companies |
| Nina Marika Wodzinski | Board of Directors | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |